Individuals homozygous for the age-related macular degeneration risk-conferring variant of complement factor H have elevated levels of CRP in the choroid
- 14 November 2006
- journal article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences of the United States of America
- Vol. 103 (46), 17456-17461
- https://doi.org/10.1073/pnas.0606234103
Abstract
Polymorphisms in the complement factor H gene (CFH) are associated with a significantly increased risk for, or protection against, the development of age-related macular degeneration (AMD). The most documented risk-conferring single-nucleotide polymorphism results in a tyrosine-to-histidine substitution at position 402 (Y402H) of the CFH protein. In this work, we examined the ocular distributions and relative abundance of CFH, several CFH-binding proteins, and abundant serum proteins in the retinal pigmented epithelium (RPE), Bruch's membrane, and choroid (RPE-choroid) in CFH homozygotes possessing either the "at-risk" 402HH or "normal" 402YY variants. Although CFH immunoreactivity is high in the choroid and in drusen, no differences in CFH-labeling patterns between genotypes are apparent. In contrast, at-risk individuals have significantly higher levels of the CFH-binding protein, C-reactive protein (CRP), in the choroidal stroma. Immunoblots confirm that at-risk individuals have approximately 2.5-fold higher levels of CRP in the RPE-choroid; no significant differences in the levels of CFH or other serum proteins are detected. Similarly, we find no differences in CFH transcription levels in the RPE-choroid nor evidence for local ocular CRP transcription. Increased levels of CRP in the choroid may reflect a state of chronic inflammation that is a by-product of attenuated CFH complement-inhibitory activity in those who possess the CFH at-risk allele. Because the CRP-binding site in CFH lies within the domain containing the Y402H polymorphism, it is also possible that the AMD risk-conferring allele alters the binding properties of CFH, thereby leading to choroidal CRP deposition, contributing to AMD pathogenesis.This publication has 52 references indexed in Scilit:
- Common variation in three genes, including a noncoding variant in CFH, strongly influences risk of age-related macular degenerationNature Genetics, 2006
- CFH haplotypes without the Y402H coding variant show strong association with susceptibility to age-related macular degenerationNature Genetics, 2006
- A Prospective Assessment of the Y402H Variant in Complement Factor H, Genetic Variants in C-Reactive Protein, and Risk of Age-Related Macular DegenerationInvestigative Ophthalmology & Visual Science, 2006
- Biomarkers of Cardiovascular Disease as Risk Factors for Age-Related Macular DegenerationOphthalmology, 2005
- Synaptic Pathology, Altered Gene Expression, and Degeneration in Photoreceptors Impacted by DrusenInvestigative Ophthalmology & Visual Science, 2005
- An interactive web database of factor H-associated hemolytic uremic syndrome mutations: insights into the structural consequences of disease-associated mutationsHuman Mutation, 2005
- The relation between C reactive protein and age related macular degeneration in the Cardiovascular Health StudyBritish Journal of Ophthalmology, 2005
- Complement Factor H Polymorphism in Age-Related Macular DegenerationScience, 2005
- Serum Amyloid P Component and C-Reactive Protein Opsonize Apoptotic Cells for Phagocytosis through Fcγ ReceptorsJournal of Autoimmunity, 2002
- C‐reactive protein‐mediated phagocytosis and phospholipase D signalling through the high‐affinity receptor for immunoglobulin G (FcγRI)Immunology, 2002